- Summits
- Sponsorship
- Media Opportunities
- News
- About
Singapore pulses with a special kind of energy this week. While the Formula 1 Grand Prix looms around the corner, the roar of engines isn’t the only thing setting the city buzzing. On 1 October, MedTech World, in collaboration with KPMG Singapore, took over the stage, and much like an F1 race, it was all about acceleration, strategy, and staying ahead of the competition.
From government leaders and investors to global corporates and ambitious startups, more than 300 trailblazers came together, sparking ideas that are transforming healthcare across ASEAN and the Asia-Pacific.
The day opened with a welcome from Dr. Dylan Attard, Chief Executive Officer, MedTech World, and Akhil Bheda, Director, KPMG Singapore, who together set the tone for what lay ahead. Both highlighted Singapore’s role as a global convergence point for MedTech, a place where cutting-edge research, regulatory readiness, and investor appetite meet.
That was followed by the Opening Keynote from John Eng, Vice President, Healthcare, Economic Development Board (EDB) Singapore, who reinforced Singapore’s position as a launchpad for global healthcare solutions. His remarks made it clear why so many innovators and investors are choosing the city-state as their base: stability, policy support, and a thriving ecosystem.
No race is won without strategy, and that came early with KPMG’s unveiling of its latest Healthcare & Life Sciences Thought Leadership Report.
shared key findings on growth opportunities, policy challenges, and the investment hotspots shaping the region. Their insights served as a pit board for stakeholders, providing data-driven signals on when to accelerate, when to hold back, and where to find the most promising overtakes.
This was followed by a powerhouse panel that spanned ASEAN and beyond:
Together, they unpacked the realities of expanding into diverse APAC markets, where regulations, funding access, and cultural nuances make every country a new kind of corner to navigate.
The startup showcases gave investors and corporates the chance to spot the disruptors.
In Startup Block I, we heard from:
Later, in Startup Block II, the stage belonged to:
These sessions weren’t typical presentations-they were test laps, demonstrating what innovation looks like in real-world healthcare contexts, while investors assessed which companies have the stamina to go the distance.
The afternoon turned tactical.
Here, health system leaders and investors stressed that pilots are only the qualifying laps. To actually make it to procurement and adoption, startups need to show measurable clinical and economic impact.
Here, the focus was scaling — navigating capital readiness, policy, and strategic partnerships in a region where no two markets are the same.
This session tackled the high-stakes risks of cybersecurity breaches, reminding everyone that in MedTech, patient trust is the engine, and resilience is the safety barrier.
In the later sessions, global investors like Dr. Amit Varma, Co-Founder & Managing Partner, Quadria Capital, Stephen Bates, Partner & Head of Deals & Advisory, KPMG Singapore, and Vijay Karwal, Managing Director, CBC Group, revealed what they look for in ASEAN-based MedTech companies. Their message was clear: global capital is watching this region closely, and the opportunity is massive.
Global tariffs are pushing MedTech startups to seek new manufacturing bases. This session explored why ASEAN is emerging as the partner of choice for production and scale-up.
Then came the focus on Singapore itself:
Together, they explained why Singapore works from its regulatory agility and research infrastructure to its supportive government initiatives. For many MedTech companies, this is the podium where success begins.
The day ended with Alfred Sia waving the chequered flag, wrapping up with key takeaways and a look at what’s next.
But the real podium moment? The networking drinks reception. Investors, founders, and corporates mingled, swapped ideas, and built connections that could define the next lap of MedTech innovation.
If the Formula 1 Grand Prix this weekend is about speed, precision, and strategy, MedTech World Singapore 2025 mirrored all of that but with healthcare innovation as the prize.
Miss this, and you’ve missed a crucial lap in the global MedTech race. But the season isn’t over. The next lap is MedTech Malta 2025 this November, followed by another major milestone with our flagship conference in Hong Kong in September 2026, bringing the MedTech race to an even bigger stage. Be there, or risk watching from the sidelines while the real action unfolds on track.
For more information, reach out to us at [email protected].
